Last post, I described some of the features of the voluntary process that might convince veterinary drug companies to give up lucrative approvals to sell antibiotics for production purposes, like growth promotion and feed efficiency. Read More
Weaker Antibiotic Regulation: Another Problem with FDA’s Voluntary Cooperation Program
February 25th, 2013
Negotiating with Drug Companies: The Horse-Trading Behind the FDA’s Voluntary Program
February 1st, 2013
After decades of dragging its feet on the issue, the FDA has finally acknowledged that the ongoing massive use of antibiotics in food animal production poses a public health risk that demands a response. Read More
